Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
4 results loaded, newest first. End of these results.
Liquidia said it reached an agreement with United Therapeutics that resolves all pending litigation between the companies. The $380.7 million will be paid in multiple installments this year and next.
The settlement resolves all pending litigation and ensures continued commercialization of YUTREPIA for pulmonary arterial hypertension.
Liquidia Corporation: Liquidia Announces Global Settlement Resolving All Pending Litigation With United Therapeutics, Ensuring Continued Commercialization Of Yutrepia In Pah Liquidia Corporation - Settlement Fully Resolves Six Ongoing Lawsuits Between Liquidia And United Therapeutics Liquidia Corporation - To Pay Net $
Liquidia says the global settlement ensures continued commercialization of YUTREPIA in PAH.